# Erythropoietin and Anemia Treatment

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/erythropoietin-and-anemia-treatment/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the role of erythropoietin and its derivatives in the treatment and management of various diseases, including anemia, chronic kidney disease, heart failure, stroke, and cancer. It explores the use of erythropoiesis-stimulating agents, neuroprotective effects, and the impact on hypoxia-inducible factors. Additionally, it addresses the association with iron deficiency and cardiovascular disease. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t11534 |
| Works | 318 |

## Topic papers all

Showing 15 of 318.

- [Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients](https://scholariq.org/papers/targeting-hypoxia-inducible-factors-for-the-treatment-of-anemia-in-chronic/)
- [Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease](https://scholariq.org/papers/correction-of-anemia-with-epoetin-alfa-in-chronic-kidney-disease/)
- [Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention](https://scholariq.org/papers/chronic-kidney-disease-and-cardiovascular-risk-epidemiology-mechanisms-and/)
- [Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia](https://scholariq.org/papers/normalization-of-hemoglobin-level-in-patients-with-chronic-kidney-disease-and/)
- [A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease](https://scholariq.org/papers/a-trial-of-darbepoetin-alfa-in-type-2-diabetes-and-chronic-kidney-disease/)
- [Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency](https://scholariq.org/papers/ferric-carboxymaltose-in-patients-with-heart-failure-and-iron-deficiency/)
- [The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin](https://scholariq.org/papers/the-effects-of-normal-as-compared-with-low-hematocrit-values-in-patients-with/)
- [Syndromes of Thrombotic Microangiopathy](https://scholariq.org/papers/syndromes-of-thrombotic-microangiopathy/)
- [Effect of Nesiritide in Patients with Acute Decompensated Heart Failure](https://scholariq.org/papers/effect-of-nesiritide-in-patients-with-acute-decompensated-heart-failure/)
- [Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency](https://scholariq.org/papers/beneficial-effects-of-long-term-intravenous-iron-therapy-with-ferric/)
- [History of Erythropoiesis-Stimulating Agents, the Development of Biosimilars, and the Future of Anemia Treatment in Nephrology](https://scholariq.org/papers/history-of-erythropoiesis-stimulating-agents-the-development-of-biosimilars-and/)
- [Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome](https://scholariq.org/papers/ultrafiltration-in-decompensated-heart-failure-with-cardiorenal-syndrome/)
- [Blood Transfusion in Elderly Patients with Acute Myocardial Infarction](https://scholariq.org/papers/blood-transfusion-in-elderly-patients-with-acute-myocardial-infarction/)
- [Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease](https://scholariq.org/papers/stroke-and-bleeding-in-atrial-fibrillation-with-chronic-kidney-disease/)
- [Survival in Medically Treated Patients with Homozygous β-Thalassemia](https://scholariq.org/papers/survival-in-medically-treated-patients-with-homozygous-thalassemia/)

## Topic primary papers

Showing 15 of 164.

- [Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients](https://scholariq.org/papers/targeting-hypoxia-inducible-factors-for-the-treatment-of-anemia-in-chronic/)
- [Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease](https://scholariq.org/papers/correction-of-anemia-with-epoetin-alfa-in-chronic-kidney-disease/)
- [Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia](https://scholariq.org/papers/normalization-of-hemoglobin-level-in-patients-with-chronic-kidney-disease-and/)
- [A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease](https://scholariq.org/papers/a-trial-of-darbepoetin-alfa-in-type-2-diabetes-and-chronic-kidney-disease/)
- [Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency](https://scholariq.org/papers/ferric-carboxymaltose-in-patients-with-heart-failure-and-iron-deficiency/)
- [The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin](https://scholariq.org/papers/the-effects-of-normal-as-compared-with-low-hematocrit-values-in-patients-with/)
- [Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency](https://scholariq.org/papers/beneficial-effects-of-long-term-intravenous-iron-therapy-with-ferric/)
- [Blood Transfusion in Elderly Patients with Acute Myocardial Infarction](https://scholariq.org/papers/blood-transfusion-in-elderly-patients-with-acute-myocardial-infarction/)
- [Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial](https://scholariq.org/papers/ferric-carboxymaltose-for-iron-deficiency-at-discharge-after-acute-heart-failure/)
- [Anemia and Mortality in Heart Failure Patients](https://scholariq.org/papers/anemia-and-mortality-in-heart-failure-patients/)
- [Iron deficiency in chronic heart failure: An international pooled analysis](https://scholariq.org/papers/iron-deficiency-in-chronic-heart-failure-an-international-pooled-analysis/)
- [Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis](https://scholariq.org/papers/roxadustat-treatment-for-anemia-in-patients-undergoing-long-term-dialysis/)
- [Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure](https://scholariq.org/papers/treatment-of-anemia-with-darbepoetin-alfa-in-systolic-heart-failure/)
- [Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis](https://scholariq.org/papers/roxadustat-for-anemia-in-patients-with-kidney-disease-not-receiving-dialysis/)
- [Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes](https://scholariq.org/papers/secondary-analysis-of-the-choir-trial-epoetin-dose-and-achieved-hemoglobin/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.